Status:

WITHDRAWN

Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)

Lead Sponsor:

CENTOGENE GmbH Rostock

Conditions:

Mental Retardation

Developmental Delay

Eligibility:

All Genders

2+ years

Brief Summary

Development of a new MS-based biomarker for the ear-ly and sensitive diagnosis of Sanfilippo Disease Type A-B-C-D from blood (plasma)

Detailed Description

The Mucopolysaccharidoses (MPS Disorders) are a group of rare genetic disorders caused by the deficiency of one of the lysosomal enzymes, resulting in an inability to metabolize complex carbohydrates ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Informed consent will be obtained from the patient or the parents before any study related procedures.
  • Patients of both genders older than 2 month
  • The patient has a diagnosis of Sanfilippo Type A-B-C-D disease or a high-grade suspicion for Sanfilippo Type A-B-C-D disease
  • High-grade suspicion present, if one or more inclusion criteria are valid:
  • Positive family anamnesis for Sanfilippo Type A-B-C-D disease
  • Dysostosis multiplex without identifiable cause
  • Splenomegaly without identifiable cause
  • Hepatomegaly without identifiable cause
  • Heparan sulfate excretion in urine
  • CNS involvement without identifiable cause
  • EXCLUSION CRITERIA:
  • No Informed consent from the patient or the parents before any study related procedures.
  • Patients of both gender younger than 2 month
  • No diagnosis of Sanfilippo Type A-B-C-D disease or no valid criteria for profound suspicion of Sanfilippo Type A-B-C-D disease

Exclusion

    Key Trial Info

    Start Date :

    August 20 2018

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    February 28 2021

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT02298686

    Start Date

    August 20 2018

    End Date

    February 28 2021

    Last Update

    February 13 2023

    Active Locations (5)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (5 locations)

    1

    Children's Hospital, Faculty of Medicine, Ain Shams University

    Cairo, Egypt, 89075

    2

    Centogene AG

    Rostock, Germany, 18055

    3

    Amrita Institute of Medical Sciences & Research Centre

    Kochi, Kerala, India, 682041

    4

    Navi Mumbai Institute of Research In Mental And Neurological Handicap (NIRMAN)

    Mumbai, India, 400705

    Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) | DecenTrialz